Hospital Implementation Guide
Establishing an evidence-based institutional leech therapy program
Clinical Evidence — Not FDA-Evaluated
This guide synthesizes published institutional protocols from major U.S. academic medical centers. All recommendations should be adapted to your facility's specific policies, formulary, and scope-of-practice requirements.
Program Establishment Checklist
Establishing a medicinal leech therapy program requires coordination across multiple hospital departments. The following checklist outlines the key milestones.
Phase 1: Administrative Approval (Weeks 1–4)
- Obtain medical staff committee approval for leech therapy protocol
- Identify physician champion (typically plastic surgery or vascular surgery)
- Establish Pharmacy & Therapeutics committee review for antibiotic prophylaxis protocol
- Secure institutional review for informed consent template
- Designate responsible departments (Plastic Surgery, Pharmacy, Nursing, Infection Control)
Phase 2: Supply Chain (Weeks 2–6)
- Select FDA-cleared supplier (Ricarimpex SAS — K040187, Biopharm UK — K132958, or Carolina Biological — K140907)
- Establish purchase agreement and delivery logistics
- Set up leech storage facility (dedicated aquarium, 15–20°C, dechlorinated water, weekly water changes)
- Develop receiving inspection protocol (verify species, assess vitality, document batch number)
- Coordinate with Materials Management for inventory tracking
Phase 3: Protocol Development (Weeks 4–8)
- Develop standardized leech therapy order set for EMR integration
- Create nursing protocol with step-by-step application and monitoring guide
- Establish antibiotic prophylaxis protocol (ciprofloxacin + TMP-SMX)
- Define hematologic monitoring schedule (CBC q4-8h during active treatment)
- Create transfusion threshold protocol (type and crossmatch standing order)
- Develop biohazard waste disposal protocol for used leeches
- Create patient/family education materials
Phase 4: Training & Go-Live (Weeks 6–10)
- Conduct nursing in-service training (leech handling, application, monitoring, removal)
- Train pharmacy staff on prophylaxis protocol and batch surveillance
- Establish competency assessment checklist for nursing staff
- Perform mock scenario (simulated leech therapy case with full protocol execution)
- Go-live with first supervised case
- Schedule 30/60/90-day program review
Supply Chain & Procurement
The FDA requires that all medicinal leeches used in the United States are sourced from 510(k)-cleared suppliers. Three suppliers currently hold active clearances.
Ricarimpex SAS
Species: Hirudo verbana
Eysines, France
Volume: see FDA AccessData to U.S.
FDA-cleared (K040187, 2004) supplier; international market leader and exclusive leech supplier in France (Ricarimpex SAS, Eysines, France).
Biopharm Leeches Ltd.
Species: Hirudo verbana
Hendy, Wales, UK
Volume:
Second FDA-cleared supplier. Welsh breeding facility.
Carolina Biological Supply Co.
Species: Hirudo verbana
Burlington, NC, USA
Volume: ~5,000 leeches/year
U.S.-based distributor. Updated labeling and indications language.
Storage Requirements
- •Temperature: 15–20°C (59–68°F) — dedicated refrigerator or temperature-controlled room
- •Water: Dechlorinated, changed weekly (or when turbid)
- •Container: Glass or food-grade plastic aquarium with secure mesh lid
- •Density: Maximum 50 leeches per 2.5 L water (manufacturer guidance); do not overcrowd
- •Feeding: Do NOT feed leeches after receipt (they should be fasting for clinical use)
- •Light: Avoid direct sunlight; low ambient light preferred
- •Storage: keep in a refrigerator or other cool, dark place (5-10 °C); leeches survive weeks, sometimes months, at these temperatures; document receipt date on container
EMR Order Set Design
EMR-integrated order sets can improve protocol adherence. The order set below is modeled on a published EMR order panel implemented at a tertiary care academic medical center (Palm et al., 2022).
Leech Therapy Order
- •Species: Hirudo verbana (FDA-cleared)
- •Quantity: _____ leeches per application
- •Frequency: q___h or PRN for venous congestion signs
- •Duration: _____ days (auto-stop at day ___)
- •Application site: _____ (specify anatomic location)
- •Barrier: Apply within gauze dam to prevent migration
Linked Prophylaxis Orders (auto-activate)
- •Ciprofloxacin 500 mg PO BID × duration of leech therapy + 24h after last application
- •TMP-SMX DS (160/800 mg) PO BID × duration of leech therapy + 24h after last application
- •Alternative for fluoroquinolone allergy: 3rd-gen cephalosporin (ceftriaxone 1g IV daily)
- •Pediatric (<18y): TMP-SMX + ceftriaxone (fluoroquinolones contraindicated)
Linked Monitoring Orders (auto-activate)
- •CBC q8h during active leech therapy (q4h if Hgb <10 g/dL)
- •Type and crossmatch on admission (maintain 2 units PRBC availability)
- •Transfusion threshold: Hgb <7 g/dL (or <8 g/dL with cardiovascular disease)
- •Coagulation panel: PT/INR, aPTT baseline and q24h
- •Wound culture: if signs of infection at bite site (erythema, purulent drainage, >38°C)
Linked Nursing Orders (auto-activate)
- •Flap/tissue assessment q1h during active treatment (color, turgor, capillary refill, temperature)
- •Document: number of leeches applied, feeding duration, post-detachment bleeding duration
- •Bite site care: moist gauze, no tight bandaging (maintain passive venous drainage)
- •Fall precautions: active bleeding patients
- •Call parameters: Hgb <8 g/dL, active bleeding >6 hours, signs of infection, hemodynamic instability
Nursing Protocol & Training
Nursing Protocol Summary
Preparation
Verify order, confirm consent, prepare supplies (gloves, gauze dam, specimen cup for used leeches, hemostatic agents). Check patient allergies and current medications.
Application
Clean application site with sterile saline (no alcohol, iodine, or antiseptics — these repel leeches). Place gauze dam barrier. Apply leech to target area using gloved hands or forceps. Allow attachment (1–5 minutes).
Monitoring
Do NOT pull or forcibly detach feeding leeches. Monitor feeding (15–60 minutes typical). Assess tissue color, turgor, and capillary refill. Document start time, number of leeches, anatomic location.
Detachment
Leeches detach spontaneously when engorged. If removal needed before spontaneous detachment: apply saline-soaked gauze to leech body (NOT salt directly on wound). Never pull an attached leech.
Post-Detachment Care
Expect 4–24 hours of post-detachment oozing (this is therapeutic — provides continued venous decompression). Apply moist gauze; do NOT apply pressure or hemostatic agents unless hemorrhage is clinically significant.
Disposal
Place used leeches in specimen cup with 70% alcohol (kills leech). Dispose as biohazard waste. Leeches are SINGLE-USE — never reuse on same or different patient.
Quality Metrics & Outcomes Tracking
Track the following metrics to assess program performance and identify improvement opportunities.
| Metric | Target | Source / Benchmark |
|---|---|---|
| Salvage Rate | ≥75% | Whitaker 2012 benchmark: 78% |
| Prophylaxis Adherence | 100% | Any omission increases infection risk 4–10× |
| Infection Rate | <5% | Reported infection rates range from about 2.4% to 20% (Maetz 2012); infections were significantly more frequent without antibiotic prophylaxis (Whitaker 2011) |
| Transfusion Rate | Monitor (expected ~50%) | Whitaker 2012: 50% in microsurgical patients |
| Time to First Leech | <24h from congestion onset | Timing evidence is surgical, not leech-specific: salvage of compromised breast free flaps 83.7% within the first 24 h vs 38.6% at days 1–3 (Chang et al. 2016) |
| Batch Culture Rate | 100% of batches | Proactive surveillance for Aeromonas resistance |